Positive impact on lives and healthcare budgets.
Podimetrics is bringing new hope to patients, payors and providers. View our favorite highlights below or see all our clinical evidence.
Reduced Complications and Amputations
In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:
Patient Experience and Adherence
In two different studies:
engaged at one year2
SmartMat “easy to use”3
Reduced Complications and Amputations
In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:
52% relative risk reduction1
† Net difference was observed despite 1.6 additional podiatry outpatient visits per-participant year resulting from inflammation detected by the study device.
Cost Savings and ROI
Podimetrics calculates up to $13,000 in annual cost savings per patient4
3.6X – 5.2X
$9,800 – 14,000
Choose innovation.
Not complications and amputations.
Learn MoreWhat's new at Podimetrics?
All NewsUnveiling the Human & Economic Impact of Diabetic Amputations
Explore the profound impact of diabetic amputations on individuals' lives and the crucial role of prevention in preserving independence and…Preserving Limbs: RTM’s Transformative Effect on Patients Like Gary
April is Limb Loss Awareness Month, a time to bring attention to the challenges faced by people with diabetes. Diabetes…Why Does Diabetes Increase the Risk of Limb Amputation?
Effective foot care plays a crucial role in the management of diabetes. Individuals with diabetes often face a higher risk…
Unveiling the Human & Economic Impact of Diabetic Amputations
Explore the profound impact of diabetic amputations on individuals' lives and the crucial role of prevention in preserving independence and…
1. Isaac, et al. BMJ Open Diab Res Care 2020
2. Rothenberg, et al. Fed Pract. 2020
3. Frykberg, et al. Diabetes Care 2017
4. Podimetrics Data on File
5. Assumptions based on 90 weeks of Intermountain Health claims data for 428 at-risk patients and applying results from our recent peer-reviewed study with Kaiser Permanente in the British Journal of Medicine (BMJ)